Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are d
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/5b7bde99ebf4bcf365c67209fb6357f7.jpg"/><p>Several weight loss drug stocks are [...]
Hims & Hers stock jumps 14% after FDA schedules peptide compounding rev
The FDA will convene an outside panel in July to weigh compounding eligibility for 7 peptides, a category Hims & Hers has been positioning to enter
[...]
Hims & Hers Expands Personalized Digital Healthcare Platform
HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.
[...]
Hims & Hers will get to sell Ozempic. Like, real Ozempic. The stock soa
Novo Nordisk and Hims had clashed on and off for months as the telehealth firm marketed compounded versions of Novo's blockbuster GLP-1 drug Wegovy
[...]